Abstract
In the process of finding new drug candidates medicinal chemists nowadays have a variety of options to choose from, one is to apply combinatorial chemistry techniques. Since the early 1990s synthetic and analytical methods as well as new technologies have been growing repidly in the area of combinatorial chemistry. Applying these techniques have resulted in the production of large numbers of compounds. A trend is observed towards smaller libraries of compounds with more drug-like properties. An analysis is made to establish the contribution of combinatorial chemistry in providing new lead candidates for (pre)clinical development towards new pharmaceutical products. Ten representative examples are given to describe the impact of ombinatorial chemistry on different levels of the lead discovery and optimization process. Furthermore, reports on combinatorial chemistry products that are already in (pre)clinical development were traced back to their source. The interim analysis showed only limied su ccess of combinatorial chemistry approaches in terms of delivering leads. Second generation libraries appear more drug-like and focused and may result in more compounds entering clinical studies in the future
Keywords: Combinatorial Chemistry, Interim Analysis, Thymidylate syntheses Inhibitors, Solid-Phase, Dansyltyrosine derivatives, Potassium channel blockers, Phenylstilbene library, Protein tyrosine kinases, Benzodiazepines, Src tyrosine
Current Medicinal Chemistry
Title: The Contribution of Combinatorial Chemistry to Lead Generation An Interim Analysis
Volume: 8 Issue: 9
Author(s): Anton E.P. Adang and Pedro H.H. Hermkens
Affiliation:
Keywords: Combinatorial Chemistry, Interim Analysis, Thymidylate syntheses Inhibitors, Solid-Phase, Dansyltyrosine derivatives, Potassium channel blockers, Phenylstilbene library, Protein tyrosine kinases, Benzodiazepines, Src tyrosine
Abstract: In the process of finding new drug candidates medicinal chemists nowadays have a variety of options to choose from, one is to apply combinatorial chemistry techniques. Since the early 1990s synthetic and analytical methods as well as new technologies have been growing repidly in the area of combinatorial chemistry. Applying these techniques have resulted in the production of large numbers of compounds. A trend is observed towards smaller libraries of compounds with more drug-like properties. An analysis is made to establish the contribution of combinatorial chemistry in providing new lead candidates for (pre)clinical development towards new pharmaceutical products. Ten representative examples are given to describe the impact of ombinatorial chemistry on different levels of the lead discovery and optimization process. Furthermore, reports on combinatorial chemistry products that are already in (pre)clinical development were traced back to their source. The interim analysis showed only limied su ccess of combinatorial chemistry approaches in terms of delivering leads. Second generation libraries appear more drug-like and focused and may result in more compounds entering clinical studies in the future
Export Options
About this article
Cite this article as:
Adang E.P. Anton and Hermkens H.H. Pedro, The Contribution of Combinatorial Chemistry to Lead Generation An Interim Analysis, Current Medicinal Chemistry 2001; 8 (9) . https://dx.doi.org/10.2174/0929867013372517
DOI https://dx.doi.org/10.2174/0929867013372517 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements